Company Filing History:
5 out of 5 
4 out of 12 
3 out of 734 
Years Active: 2001-2017
Title: The Innovations of Arie L. Gutman
Introduction
Arie L. Gutman is a prominent inventor based in Haifa, Israel, known for his significant contributions to the field of cannabinoid research. With an impressive portfolio of 23 patents, Gutman has focused on developing methods related to tetrahydrocannabinol, which is crucial for various therapeutic applications.
Latest Patents
Among his latest innovations, Gutman has disclosed methods for producing both trans-(-)-tetrahydrocannabinol and trans-(+)-tetrahydrocannabinol. One of his notable compositions achieves a remarkable purity of at least 99% by weight of trans-(-)-tetrahydrocannabinol. This composition is vital in formulating treatments aimed at alleviating conditions such as pain. By utilizing a chiral stationary phase, the separation process optimizes the purity of these cannabinoid compounds, enhancing their efficacy for medical use.
Career Highlights
Throughout his career, Arie L. Gutman has collaborated with well-established companies, including Finetech Laboratories Ltd. and Fine Tech Corporation. His role in these organizations has significantly influenced research and development in cannabinoid applications, leading to his numerous patents and academic contributions in the field.
Collaborations
Collaboration is a key aspect of Gutman's work. He has worked alongside notable colleagues such as Gennady Nisnevich and Boris Tishin. Their combined expertise has fostered innovative approaches to cannabinoid chemistry, furthering the impact of their research in therapeutic applications.
Conclusion
Arie L. Gutman continues to be a pivotal figure in the advancement of cannabinoid research and its practical applications. With his extensive patent portfolio and collaborations in the industry, he is poised to make further significant contributions to the field, enhancing the understanding and utilization of tetrahydrocannabinol in modern medicine.